4
Changes in Ownership
Whitehawk Therapeutics, Inc. Filed Acc 0000899243-18-010747
Options or other derivatives
- Chief Financial Officer acquired 144,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
ROGERS MICHAEL W · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-04-23 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +144,000 | 144,000 | D |
Loading xslF345X03/doc4.xml…